Literature DB >> 2038995

Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens.

J Sarosiek1, B J Marshall, D A Peura, S Hoffman, T Feng, R W McCallum.   

Abstract

The gastroduodenal mucus layer is considered the primary mucosal protective barrier, especially important in the maintenance of a mucosal pH gradient. Thus, the measurement of the mucus layer thickness in various disease states could advance our understanding of gastroduodenal pathophysiology. We present a novel method for measuring the mucus layer in endoscopic biopsy material and compare layer thickness in Helicobacter pylori (HP)-negative and HP-positive specimens. Endoscopic biopsies were obtained from 17 patients with gastroduodenal mucosa harboring HP and from 15 patients without current HP colonization. The thickness of the mucus layer was measured in fresh specimens by the phase-contrast dark-field microscopy technique. In patients with confirmed HP infection, the thickness of the mucus layer (mean +/- SD) was 0.093 +/- 0.033 mm in duodenal, 0.085 +/- 0.027 mm in antral, and 0.105 +/- 0.033 mm in corporal mucosa. In patients without concomitant HP colonization, the thickness of the mucus gel was 0.162 +/- 0.045 mm, 0.175 +/- 0.067 mm, and 0.161 +/- 0.064 mm in duodenum, antrum, and corpus, respectively. The differences between the means were statistically significant (p less than 0.001 for the duodenal, p less than 0.001 for antral, and p less than 0.01 for corporal mucosa). This study suggests that colonization of the gastroduodenal mucosa by HP impairs the mucus layer covering the surface epithelium. This mucus layer impairment may lead to mucosal injury with subsequent development of inflammation and, possibly, peptic ulcer disease.

Entities:  

Mesh:

Year:  1991        PMID: 2038995

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  16 in total

1.  Role of vacA and cagA in Helicobacter pylori inhibition of mucin synthesis in gastric mucous cells.

Authors:  W Beil; M L Enss; S Müller; B Obst; K F Sewing; S Wagner
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects.

Authors:  A Mattsson; M Quiding-Järbrink; H Lönroth; A Hamlet; I Ahlstedt; A Svennerholm
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 3.  Protective Factors of the Gastric and Duodenal Mucosa: An Overview.

Authors:  Harathi Yandrapu; Jerzy Sarosiek
Journal:  Curr Gastroenterol Rep       Date:  2015-06

4.  Effect of Helicobacter pylori on the gastric mucus gel.

Authors:  M Guslandi
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

5.  Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.

Authors:  T Jaworski; I Sarosiek; S Sostarich; K Roeser; M Connor; S Brotze; G Wallner; J Sarosiek
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

6.  Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders.

Authors:  T Skoczylas; I Sarosiek; S Sostarich; C McElhinney; S Durham; J Sarosiek
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

7.  Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised.

Authors:  J L Newton; N Jordan; L Oliver; V Strugala; J Pearson; O F James; A Allen
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model.

Authors:  Mohammed S Al-Marhoon; Sheila Nunn; Roger W Soames
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

9.  Declined human esophageal mucin secretion in patients with severe reflux esophagitis.

Authors:  Z Namiot; J Sarosiek; M Marcinkiewicz; M C Edmunds; R W McCallum
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

10.  Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.

Authors:  Katsunori Iijima; T Ichikawa; S Okada; M Ogawa; T Koike; S Ohara; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.